PharmD, MBA Head of Global Clinical Supply

Dr. Michael Ku is Vice President of Global Clinical Supply (GCS) within the Medicinal Sciences organization
of Pfizer’s Worldwide Research, Development and Medical division. Michael has over 25 years of
biopharmaceutical experience and currently provides strategic leadership for clinical supply chain
functions in support of Pfizer’s clinical trials in over 70 countries. His intellectual curiosity and focus on
technology and innovation drive his passion to lead the global clinical supply chain to deliver
breakthroughs to patients, especially with the Comirnaty® vaccine and Paxlovid® antiviral programs.

Prior to joining Pfizer, Michael was the Global Head and Vice President of Clinical Pharmacy Research
Services (CPRS) at Genzyme Corporation (currently Sanofi). He also held several roles of increasing
responsibility at Astra Pharmaceuticals (currently AstraZeneca) and Novopharm Limited (currently Teva
Canada Limited) in the areas of Clinical Research, Pharmacovigilance, Regulatory Affairs and Quality
Assurance.

Inspired by helping to unleash the potential for pharmacists globally at Pfizer, Michael also serves as an
Executive Sponsor for the Pfizer Pharmacy Association (PPA) and founded the Pfizer/MCPHS
Biopharmaceutical Fellowship Program as its Program Director and Assistant Professor of Pharmacy
Practice at MCPHS University.

Having a deep appreciation for talent development and motivated by helping Pfizer colleagues thrive,
Michael shares his leadership skills with a focus on diversity, equity and inclusion by serving as the
Executive Leader of the Global Asian Alliance Enterprise Colleague Resource Group (GAA ECRG).

In 2018, he received the prestigious Outstanding 50 Asian Americans in Business Award. Michael was also
honored as a recipient of the 2022 Ascend A-List Award which celebrated resilient, courageous Asian
business leaders and executives for both their professional achievements and commitment to their
communities.

Michael’s educational background includes a Doctor of Pharmacy and Bachelor’s Degree in Pharmacy from
MCPHS University as well as a Master’s Degree in Business Administration from Anna Maria College. He
also holds a Bachelor of Science Degree in Toxicology from the University of Toronto and is a graduate of
the General Management Program from Harvard Business School.